These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 34291190)

  • 1. microRNAs involved in psoriasis and cardiovascular diseases.
    Sileno S; Beji S; D'Agostino M; Carassiti A; Melillo G; Magenta A
    Vasc Biol; 2021; 3(1):R49-R68. PubMed ID: 34291190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.
    Hu SC; Lan CE
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29065479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriasis and Vascular Risk : An Update.
    Katsiki N; Anagnostis P; Athyros VG; Karagiannis A; Mikhailidis DP
    Curr Pharm Des; 2014; 20(39):6114-25. PubMed ID: 24745923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic markers for cardiovascular disease in psoriasis: the missing piece.
    Torres T; Chiricozzi A; Chimenti S; Saraceno R
    Mol Diagn Ther; 2014 Feb; 18(1):93-5. PubMed ID: 24078347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologics for Reducing Cardiovascular Risk in Psoriasis Patients.
    Terui H; Asano Y
    J Clin Med; 2023 Feb; 12(3):. PubMed ID: 36769825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoriasis as a cardiovascular risk factor: updates and algorithmic approach.
    Cozzani E; Rosa GM; Burlando M; Parodi A
    G Ital Dermatol Venereol; 2018 Oct; 153(5):659-665. PubMed ID: 29683293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients.
    Wakkee M; Thio HB; Prens EP; Sijbrands EJ; Neumann HA
    Atherosclerosis; 2007 Jan; 190(1):1-9. PubMed ID: 16942772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriasis and Cardiometabolic Diseases: Shared Genetic and Molecular Pathways.
    Piaserico S; Orlando G; Messina F
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The concept of psoriasis as a systemic inflammation: implications for disease management.
    Reich K
    J Eur Acad Dermatol Venereol; 2012 Mar; 26 Suppl 2():3-11. PubMed ID: 22356630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining the risk of cardiovascular disease in patients with psoriasis: a critical review.
    Papp K; Poulin Y; Vieira A
    J Cutan Med Surg; 2013; 17(2):89-105. PubMed ID: 23582163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of cardio-metabolic risk profile in patients with psoriasis.
    Karoli R; Fatima J; Shukla V; Dhillon KS; Khanduri S; Maini S; Chandra A
    J Assoc Physicians India; 2013 Nov; 61(11):798-803. PubMed ID: 24974491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk in patients with plaque psoriasis and psoriatic arthritis without a clinically overt cardiovascular disease: the role of endothelial progenitor cells.
    Michalska A; Teichman R; Kręcisz B; Siudak Z; Stępień R; Sadowski M
    Postepy Dermatol Alergol; 2020 Jun; 37(3):299-305. PubMed ID: 32774211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoriasis: the visible killer.
    Torres T; Bettencourt N
    Rev Port Cardiol; 2014 Feb; 33(2):95-9. PubMed ID: 24525359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic Stress-Related Neural Activity Associates With Subclinical Cardiovascular Disease in Psoriasis: A Prospective Cohort Study.
    Goyal A; Dey AK; Chaturvedi A; Elnabawi YA; Aberra TM; Chung JH; Belur AD; Groenendyk JW; Lerman JB; Rivers JP; Rodante JA; Harrington CL; Varghese NJ; Sanda GE; Baumer Y; Sorokin AV; Teague HL; Genovese LD; Natarajan B; Joshi AA; Playford MP; Bluemke DA; Chen MY; Alavi A; Pitman RK; Powell-Wiley TM; Tawakol A; Gelfand JM; Mehta NN
    JACC Cardiovasc Imaging; 2020 Feb; 13(2 Pt 1):465-477. PubMed ID: 30448131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach.
    Späh F
    Br J Dermatol; 2008 Aug; 159 Suppl 2():10-7. PubMed ID: 18700910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoriasis as a systemic disease.
    Grozdev I; Korman N; Tsankov N
    Clin Dermatol; 2014; 32(3):343-50. PubMed ID: 24767182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriasis a Cause of Cardiovascular Diseases: A Review Article.
    Gupta A; Madke B
    Cureus; 2022 Aug; 14(8):e27767. PubMed ID: 36106203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular Involvement in Psoriasis, Diagnosing Subclinical Atherosclerosis, Effects of Biological and Non-Biological Therapy: A Literature Review.
    Valaiyaduppu Subas S; Mishra V; Busa V; Antony I; Marudhai S; Patel M; Cancarevic I
    Cureus; 2020 Oct; 12(10):e11173. PubMed ID: 33262910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond the Skin Plaques: Psoriasis and Its Cardiovascular Comorbidities.
    Kakarala CL; Hassan M; Belavadi R; Gudigopuram SVR; Raguthu CC; Gajjela H; Kela I; Sange I
    Cureus; 2021 Nov; 13(11):e19679. PubMed ID: 34976467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of cardiovascular risk factors in patients with psoriasis.
    Neimann AL; Shin DB; Wang X; Margolis DJ; Troxel AB; Gelfand JM
    J Am Acad Dermatol; 2006 Nov; 55(5):829-35. PubMed ID: 17052489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.